Donald Rucker, MD, Chief Strategy Officer for 1upHealth
Payer-provider relations are undergoing a major shift. The classic adversarial battles in the fee-for-service world are gradually giving way to capitated plans with more win-win incentives. The…
Continue Reading
News
AI clinical documentation company Abridge is reportedly looking to raise new funding that would put its valuation at $5 billion, double its value earlier this year when it announced $250 million in Series D…
Continue Reading
What You Should Know:
– Medtronic today announced its strategic decision to separate its Diabetes business into a new, independent, publicly traded company (“New Diabetes Company”).
– The move aims to create a more focused Medtronic,…
Continue Reading
The value of filling out forms to convey information in a consistent fashion was recognized in ancient times when writing was invented. Forms are the basis of information collection, data sharing, and regulatory compliance…
Continue Reading
Phase Scientific, a company developing urine-based diagnostics tests for early disease detection, announced it completed a $34 million Series A funding round. A private equity fund managed by Asia-based Value Partners Group led the round,…
Continue Reading
So many in healthcare today have such high hopes for artificial intelligence to do everything from defeating clinician burnout to advancing medical research. The challenge with AI in healthcare is not excitement, there’s plenty…
Continue Reading
What You Should Know:
– Altais and Autonomize AI today announced a strategic partnership aimed at reducing the rising administrative burden on care management and clinical quality teams.
– Altais will introduce Autonomize AI Copilots—intelligent digital tools…
Continue Reading
What You Should Know:
– Pharmacy Quality Solutions (PQS), an Innovaccer company and leader in pharmacy-payer performance technology, today announced the launch of EQUIPP Copilot™, the industry’s first workflow-integrated intelligence platform designed to help pharmacies…
Continue Reading
In todayâs rapidly evolving healthcare environment, there is mounting pressure for healthcare organizations to carefully consider where to invest their limited funds and strategic resources. To warrant investment, organizational initiatives must clearly demonstrate value,…
Continue Reading
Determining tumor microsatellite status has significant clinical value because tumors that are microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) respond well to immune checkpoint inhibitors (ICIs) and oftentimes not to chemotherapeutics. We propose…
Continue Reading
